Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BTC
ClearShares Piton Intermediate Fixed Income ETF
$90.36
-0.3%
$91.51
$98.48
$100.89
$29.37MN/A1,456 shs3,428 shs
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
$29.40
-0.3%
$29.88
$28.25
$37.65
$65.63B0.535.00 million shs5.63 million shs
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
$0.08
$0.12
$0.07
$1.42
$2.79M1.972.36 million shs528,287 shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BTC
ClearShares Piton Intermediate Fixed Income ETF
0.00%-0.04%-1.68%-1.52%-8.59%
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
-0.31%+2.01%-1.61%-0.91%-21.26%
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
+0.52%-7.50%-43.61%-52.62%+7,769,900.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BTC
ClearShares Piton Intermediate Fixed Income ETF
N/AN/AN/AN/AN/AN/AN/AN/A
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
2.2522 of 5 stars
0.05.02.50.02.90.01.3
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BTC
ClearShares Piton Intermediate Fixed Income ETF
0.00
N/AN/AN/A
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
2.67
Moderate BuyN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BTC
ClearShares Piton Intermediate Fixed Income ETF
N/AN/AN/AN/AN/AN/A
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
$33.94B1.93$18.61 per share1.58$26.80 per share1.10
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
$14.73M0.19N/AN/A$0.12 per share0.65

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BTC
ClearShares Piton Intermediate Fixed Income ETF
N/AN/A0.00N/AN/AN/AN/AN/A
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
-$17.87BN/A0.005.831.24N/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
-$9.64M-$3.82N/A1.11N/A-65.46%-150.14%-53.48%5/28/2024 (Estimated)

Latest NBY, BTI, DEST, 1AD, and BTC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/26/2024Q4 2023
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/A-$0.95-$0.95-$0.57N/A$3.73 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BTC
ClearShares Piton Intermediate Fixed Income ETF
$0.020.02%N/AN/AN/A
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
$2.939.97%+1.97%N/A1 Years
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/AN/A

Latest NBY, BTI, DEST, 1AD, and BTC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/14/2024
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
quarterly$0.74319.6%12/20/202412/20/20242/6/2025
2/13/2024
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
quarterly$0.74319.6%12/20/202412/20/20242/6/2025
2/12/2024
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
quarterly$0.74319.5%6/28/20246/28/20248/7/2024
2/8/2024
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
Quarterly$0.73309.53%3/21/20243/22/20245/7/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BTC
ClearShares Piton Intermediate Fixed Income ETF
N/AN/AN/A
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
0.67
0.91
0.59
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/A
1.67
1.00

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BTC
ClearShares Piton Intermediate Fixed Income ETF
147,000325,000N/ANot Optionable
British American Tobacco p.l.c. stock logo
BTI
British American Tobacco
46,0002.23 billion2.23 billionOptionable
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
2436.06 million35.59 millionNot Optionable

NBY, BTI, DEST, 1AD, and BTC Headlines

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

ClearShares Piton Intermediate Fixed Income ETF

NYSEARCA:BTC
British American Tobacco logo

British American Tobacco

NYSE:BTI
British American Tobacco p.l.c. engages in the provision of tobacco and nicotine products to consumers worldwide. It also offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company offers its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Camel, Natural American Spirit, Newport, Vogue, Viceroy, Kool, Peter Stuyvesant, Craven A, State Express 555 and Shuang Xi brands. It also distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.
NovaBay Pharmaceuticals logo

NovaBay Pharmaceuticals

NYSE:NBY
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.